HLA class II transgenic mouse models for S. aureus infections and superantigens

用于金黄色葡萄球菌感染和超抗原的 HLA II 类转基因小鼠模型

• 批准号: 8646845
• 负责人: CHELLA S DAVID
• 金额: $ 39.75万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8646845
• 关键词: Address; Alleles; Animal Model; Antibiotic Resistance; Antibodies; Bacteria; Benign; Binding; Biochemical; Biological; Bone Marrow; Cells; Chimera organism; Clinical; Disease; Disease Outcome; Enterocytes; Exotoxins; Exposure to; Family; Functional disorder; Genetic Polymorphism; Goals; HLA-DQ Antigens; HLA-DQ6; HLA-DQ8 antigen; HLA-DR Antigens; HLA-DR2 Antigen; HLA-DR3 Antigen; HLA-DR4 Antigen; Health; Human; Immune response; Immunity; Immunologic Markers; Incidence; Individual; Infection; Infectious Skin Diseases; Inflammation; Institutes; Interferon Type II; Interferons; Intestines; Investigation; Kidney; Life; Liver; Lung; MHC Class II Genes; Mediating; Mediator of activation protein; Mind; Modeling; Molecular; Mouse Strains; Mus; Organ; Organism; Outcome; Pathogenesis; Pathogenicity; Pathology; Pathway interactions; Patients; Play; Pneumonia; Prevention strategy; Production; Resistance; Role; Route; Sepsis; Series; Staphylococcal Enterotoxin B; Staphylococcus aureus; Streptococcus pyogenes; Superantigens; Syndrome; T-Cell Activation; T-Lymphocyte; TNFRSF10A gene; Therapeutic; Therapeutic Uses; Time; Toxic Shock Syndrome; Toxin; Transgenic Mice; Virulence; chemokine; cohort; cytokine; immunopathology; in vivo; insight; interest; methicillin resistant Staphylococcus aureus; mortality; mouse model; novel; receptor; resistant strain; response; weapons

DESCRIPTION (provided by applicant): Staphylococcus aureus is a ubiquitous Gram-positive organism implicated in a spectrum of diseases; from benign, localized skin infections to life-threatening, systemic illnesses including pneumonia, sepsis and menstrual or non-menstrual toxic shock syndromes (TSS). The virulence and pathogenicity of S. aureus is attributed to its several exotoxins. The superantigen exotoxins (SAg) are important amongst them because SAg are the most potent activators of T lymphocytes known. Certain SAg could also be used as biological weapons. Thus, SAg are important from many perspectives. Nonetheless, the molecular pathways by which SAg participate in the disease pathogenesis have not been completely understood due to lack of good animal models. The conventional mouse strains are resistant to TSS due to poor binding of SAg to mouse MHC class II. However, SAg binds more efficiently to human MHC (called HLA) class I molecules. Therefore, mice transgenically expressing HLA class II molecules readily succumb to the pathogenic effects of SAg delivered through different routes and to S. aureus infection. As the disease caused by SAg in HLA class II (HLA-DR3) transgenic mice also closely mimics the syndrome in humans, they are ideal models. Using this mouse model we have demonstrated that interferon-gamma (IFN-?) dependent small intestinal pathology plays a critical role in lethality associated with TSS. However, the molecular pathways by which INF-¿ contributes to lethality in TSS, either directly or indirectly through other mediators, are not clear. Therefore, it is proposed to (1) Delineate th mechanisms by which IFN-¿ plays a lethal role in staphylococcal SAg-induced TSS. This will be achieved by generating bone marrow chimeras between HLA-DR3.IFN-?R+/+ and HLA-DR3.IFN-?R-/- mice. Bone marrow chimeras will be challenged with SEB and several molecular pathways will be compared. However, IFN-? is also important for immunity S. aureus infections. Therefore, it is proposed to (2) Determine the role of IFN-? in the pathogenesis and immunity to MRSA-induced pneumonia and sepsis. This wil be accomplished by inducing pneumonia and sepsis in HLA-DR3.IFN-?+/+ and HLA-DR3.IFN-?R-/- mice with the MRSA isolate, USA300. Several bacteriological, immunological, biochemical and pathological parameters including mortality will be compared between these two lines of mice. It is known that HLA class II polymorphisms could strongly influence the magnitude of T cell activation and IFN-? production in response to streptococcal SAg. However, the impact of HLA-DR and HLA-DQ polymorphisms on staphylococcal SAg-driven immuneresponses has not been investigated. Therefore, it is proposed to (3) Determine the extent to which staphylococcal superantigen-induced IFN-? production is modulated by HLA class II polymorphisms thereby influencing the outcome of MRSA-induced pneumonia and sepsis. This will be investigated by a series of in vivo studies using transgenic mice expressing HLA-DR2, HLA-DR3, HLA-DR4, HLA-DQ2, HLA-DQ6 or HLA-DQ8 molecules.

描述（由申请方提供）：金黄色葡萄球菌是一种普遍存在的革兰氏阳性微生物，涉及一系列疾病;从良性局部皮肤感染到危及生命的全身性疾病，包括肺炎、败血症和月经或非月经中毒性休克综合征（TSS）。结果表明，该菌的毒力和致病性均较强。金黄色葡萄球菌是由于它的几种外毒素。超抗原外毒素（SAg）是其中重要的，因为SAg是已知的最有效的T淋巴细胞活化剂。某些SAg也可以用作生物武器。因此，SAg从许多角度来看都很重要。然而，由于缺乏良好的动物模型，SAg参与疾病发病机制的分子途径尚未完全了解。常规小鼠品系由于SAg与小鼠II类MHC的结合差而对TSS具有抗性。然而，SAg更有效地结合人类MHC（称为HLA）I类分子。因此，转基因表达HLA II类分子的小鼠容易屈服于通过不同途径递送的SAg的致病作用和S.金黄色葡萄球菌感染。由于SAg在HLA-DR 3转基因小鼠中引起的疾病也与人类的综合征非常相似，因此它们是理想的模型。使用这种小鼠模型，我们已经证明，干扰素-γ（IFN-？）依赖性小肠病理在TSS相关致死性中起关键作用。然而，INF-β直接或间接通过其他介质导致TSS致死的分子途径尚不清楚。因此，建议（1）阐明IFN-γ在葡萄球菌SAg诱导的TSS中发挥致死作用的机制。这将通过产生HLA-DR 3之间的骨髓嵌合体来实现。R+/+和HLA-DR 3。R-/-小鼠将用SEB挑战骨髓嵌合体，并将比较几种分子途径。然而，IFN-？对于免疫力S也很重要。金黄色葡萄球菌感染因此，建议（2）确定IFN-？在MRSA诱导的肺炎和败血症的发病机制和免疫中的作用。这将通过在HLA-DR 3中诱导肺炎和脓毒症来实现。IFN-？+/+和HLA-DR 3。IFN-？具有MRSA分离株USA 300的R-/-小鼠。将比较这两个品系小鼠的几个细菌学、免疫学、生化和病理学参数，包括死亡率。它是已知的，HLA II类多态性可以强烈影响T细胞活化和IFN-？对链球菌SAg的反应。然而，HLA-DR和HLA-DQ多态性对葡萄球菌SAg驱动的免疫应答的影响尚未研究。因此，建议（3）确定葡萄球菌超抗原诱导IFN-？HLA-II类多态性调节其产生，从而影响MRSA诱导的肺炎和脓毒症的结果。这将通过使用表达HLA-DR 2、HLA-DR 3、HLA-DR 4、HLA-DQ 2、HLA-DQ 6或HLA-DQ 8分子的转基因小鼠的一系列体内研究来研究。